Group 1 - The National Development and Reform Commission will hold a press conference on the "Modern Capital Metropolitan Area Spatial Coordination Plan (2023-2035)" [1] - The Ministry of Commerce will hold a press conference to introduce recent key work in the business sector [2] - A total of 9 companies will have their restricted shares unlocked today, with a total unlock volume of 209 million shares, amounting to a market value of 2.644 billion yuan [3] Group 2 - 13 companies have disclosed stock repurchase progress, with 5 companies announcing new repurchase plans and 3 companies reporting on the implementation of their repurchase plans [4] - The highest repurchase plan amount disclosed is 100 million yuan by Chuzhou Dongfeng, followed by 927,200 yuan by Baiyang Co., and 635,400 yuan by Yanzhou Energy [4] - The highest repurchase amounts implemented include 141 million yuan by Beiyinmei, 60.89 million yuan by Yingfeng Co., and 18.61 million yuan by Huitai Medical [4] Group 3 - The U.S. January existing home sales annualized total data will be released [5]

Group 1 - Company Huatai Medical announced on February 11 that it repurchased 77,000 shares through centralized bidding, accounting for approximately 0.05% of the total share capital of about 141 million shares [1] - The highest price for the repurchase was 242.27 yuan per share, while the lowest price was 241 yuan per share, with a total payment of approximately 18.61 million yuan [1] Group 2 - The emergence of a new Chinese video model, described as "the strongest on the surface," can generate 15-second videos for commercial delivery with just a few prompt words, leading to a surge in film and television stocks [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 证券代码：688617 证券简称：惠泰医疗 公告编号：2026-006 深圳惠泰医疗器械股份有限公司 关于以集中竞价方式首次回购股份的公告 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，现将公司首次实施回购股份情况公告如下： 2026 年 2 月 11 日，公司通过集中竞价交易方式首次回购公司股份 77,000 股， 占公司总股本 141,030,049 股的比例约为 0.05%，回购成交的最高价为 242.27 元/ 股，最低价为 241.00 元/股，支付的资金总额为人民币 18,605,600.00 元（不含印花 税、交易佣金等交易费用）。 本次回购股份符合相关法律法规及公司回购股份方案的规定。 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2026/2/10，由董事会提议 | | | | | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2026 年 2 月 9 12 月 8 | ...

证券代码：688617 证券简称：惠泰医疗 公告编号：2026-005 二、公司前十名无限售条件股东持股情况 | 序号 | 股东名称 | 持股数量（股） | 占公司总股 | | --- | --- | --- | --- | | | | | 本比例（%） | | 1 | 深圳迈瑞科技控股有限责任公司 | 32,508,228 | 23.05 | | 2 | 成正辉 | 23,551,232 | 16.70 | | 3 | 香港中央结算有限公司 | 8,380,590 | 5.94 | | 4 | 珠海彤昇投资合伙企业（有限合伙） | 4,909,960 | 3.48 | | 5 | 招商银行股份有限公司－华夏上证科创板 | 50 3,188,292 | 2.26 | | | 成份交易型开放式指数证券投资基金 | | | | 6 | 中国银行股份有限公司－华宝中证医疗交易 | 2,577,144 | 1.83 | | | 型开放式指数证券投资基金 | | | | 7 | 徐轶青 | 2,520,320 | 1.79 | | 8 | 中国银行股份有限公司－易方达蓝筹精选混 | 2,500,000 | 1.77 | ...

Core Viewpoint - The performance of the China Securities Guangdong-Hong Kong-Macao Greater Bay Area Development Theme Index and its related ETF reflects the market dynamics and investment opportunities within the Greater Bay Area, with notable fluctuations in constituent stocks and trading activity [2][3]. Group 1: Index Performance - As of February 10, 2026, the China Securities Guangdong-Hong Kong-Macao Greater Bay Area Development Theme Index (931000) decreased by 0.01% [2]. - The Greater Bay Area ETF (512970) also saw a decline of 0.13%, with the latest price at 1.52 yuan [2]. - Over the past week, the Greater Bay Area ETF has accumulated a rise of 0.93% [2]. Group 2: Stock Movements - Among the constituent stocks, Zhao Chi Co. led with a gain of 9.96%, followed by Xinlitai with an increase of 6.88%, and Huitai Medical up by 5.15% [2]. - Conversely, Mingyang Smart Energy experienced the largest drop at 4.34%, followed by Xinwei Communication down 4.08%, and Jiejia Weichuang down 3.45% [2]. Group 3: Trading Activity - The trading volume for the Greater Bay Area ETF was active, with a turnover rate of 14.53% and a transaction value of 11.4673 million yuan [2]. - The average daily trading volume over the past week was 2.6276 million yuan [2]. Group 4: Risk and Return Metrics - The maximum drawdown for the Greater Bay Area ETF this year was 5.52%, with a relative benchmark drawdown of 0.02% [2]. - The Sharpe ratio for the Greater Bay Area ETF over the past year was reported at 1.41 as of February 6, 2026 [2]. Group 5: Fee Structure - The management fee for the Greater Bay Area ETF is set at 0.15%, while the custody fee is 0.05% [2]. Group 6: Index Composition - The index closely tracks companies benefiting from the Greater Bay Area's development, with the top ten weighted stocks accounting for 44.55% of the index [3]. - The top ten stocks include China Ping An, Luxshare Precision, BYD, and others, with varying weight percentages [4].

Group 1 - On February 10, brokerages set target prices for listed companies with notable increases for Kehua Data, Nanwei Medical, and Fulete, with target price increases of 19.70%, 18.54%, and 14.09% respectively, belonging to the other power equipment, medical devices, and photovoltaic equipment industries [1][3] - A total of 21 listed companies received brokerage recommendations on February 10, with companies like Bailong Oriental, Chiplink Integration, and Tianrun Industrial each receiving one recommendation [3] - One company, Haomai Technology, had its rating upgraded from "Hold" to "Buy" by Guotou Securities on February 10 [4][5] Group 2 - Three companies received initial coverage on February 10, including Xin'ao Co., which was rated "Buy" by Shenda Securities, Bichu Electronics rated "Increase" by Jianghai Securities, and Huitai Medical rated "Buy" by Huayuan Securities [5][6] - The companies receiving initial coverage are in the textile manufacturing, computer equipment, and medical device industries [6]

Core Viewpoint - The China Securities Medical Index (399989) closed at 7197.66 points on February 10, with a 0.5% increase and a trading volume of 19.639 billion yuan, indicating a stable performance in the medical sector [1]. Group 1: Index Performance - The index saw 25 constituent stocks rise, with Huitai Medical leading the gains at 5.15%, while 24 stocks declined, with Huaxi Biological leading the losses at 3.36% [1]. - The turnover rate for the index was 1.82%, reflecting moderate trading activity [1]. Group 2: Capital Flow - The net inflow of main funds into the constituent stocks of the index totaled 554 million yuan, indicating positive institutional interest [2]. - Retail investors experienced a net outflow of 416 million yuan, suggesting a cautious sentiment among individual investors [2]. - Speculative funds saw a net outflow of 159 million yuan, indicating reduced trading activity from this segment [2].

Group 1 - The National Health Commission will hold a press conference on health related to seasonal solar terms (Beginning of Spring, Rain Water) on February 10 at 3 PM [1] Group 2 - On February 10, a total of 10 companies will have their restricted shares unlocked, with a total unlock volume of 44.2848 million shares, amounting to a market value of 788 million yuan [2] - The companies with the highest unlock volumes are Wuchan Jinlun (31.0708 million shares), Kanni Electric (6.3688 million shares), and Best (1.7789 million shares) [2] - In terms of unlock market value, Wuchan Jinlun leads with 499 million yuan, followed by Xianglou New Materials (90.3502 million yuan) and Kanni Electric (45.346 million yuan) [2] - The highest unlock ratios relative to total share capital are Wuchan Jinlun (13.97%), Xianglou New Materials (1.26%), and Yintuwanglian (1.1%) [2] Group 3 - Thirteen companies disclosed stock repurchase progress on February 10, with four companies announcing new repurchase plans, four plans approved by shareholders, one company reporting implementation progress, and four plans completed [3] - The companies with the highest proposed repurchase amounts are Huitai Medical, Dalian Technology, and Kaiying Network, each planning to repurchase up to 200 million yuan [3] - The companies with the highest repurchase amounts approved by shareholders are Yunyi Electric (150 million yuan), Zhend Medical (40.5682 million yuan), and Hubei Yihua (2.67 million yuan) [3] Group 4 - Retail sales data for the United States for December 2025 will be released [4]

证券研究报告 晨会 hyzqdatemark 2026 年 02 月 10 日 投资要点： 资料来源：聚源，华源证券研究所，截至2026年02月10日 华源晨会精粹 20260210 汽车 矿山无人驾驶专题 1:矿山无人驾驶商业模式&市场规模——汽车行业周报：为 什么看好无人矿卡赛道：1）自动驾驶大规模商业化落地进展最快的下游之一且市场 天花板较高；2）技术较为成熟，经济性突出；3）政策鼓励危险场景无人化；4）出 海逻辑清晰；5）格局初定且有较高行业壁垒；以上因素共同决定了行业龙头厂商或 具备长期成长性&投资价值。矿山无人驾驶致力于解决诸多行业痛点问题："矿区通 常地处偏远+作业环境恶劣+健康风险大+劳动强度大"引致招工难、用工贵；"装备 自动化程度低+生产系统碎片化"引致生产效率低。而这其中运输环节用工占比接近 全矿劳动员工的 50%，属于核心降本增效环节。产品模式下无人矿卡赛道市场规模： 产品模式下，下游一次性买断无人矿卡全生命周期服务（车+智驾套件/单独套件）； 该模式对于无人矿卡服务提供商的优点是"轻资产+回款快"；我们测算这种商业模 式下，中长期的国内市场规模区间预计超 200 亿元。 风险提示：1 ...

截至2026年2月10日 13:20，中证医药及医疗器械创新指数(931484)上涨0.57%，成分股惠泰医疗上涨 4.86%，海思科上涨3.61%，康龙化成上涨2.55%，药明康德上涨2.31%，恩华药业上涨1.89%。医疗创新 ETF(516820)上涨0.55%，最新价报0.37元。 消息面上，2月9日，1-8批国家集采药品新一轮接续采购开标产生拟中选结果。本次接续采购涉及1-8批 国家集采的316种常用药品，覆盖抗感染、抗肿瘤、降血糖、降血压、降血脂、神经系统、呼吸系统、 消化系统等26个治疗领域。全国5.1万家医药机构参加报量，共1091家国内外企业的4623个产品参与投 标，1020家企业的4163个产品获得拟中选资格。 东海证券指出，小核酸赛道的高景气度持续延续，从罕见病向慢病领域加速渗透，市场规模持续扩容； 跨国药企布局意愿提升，国内本土企业技术获国际认可，出海路径清晰，供应链优势凸显，板块投资价 值持续提升。后续投资建议聚焦三大核心主线：一是具备核心递送技术、拥有国际合作潜力的新锐 biotech；二是布局慢病领域（心血管、代谢等）、管线进度领先、可复制Leqvio商业化路径的行业龙 头；三 ...